Inventor · disambiguated record
Harald App
Also filed as: APP HARALD
14 granted patents·1 pending application·930 citations·filing 1994–2003
95Inventor score
Top patents by PatentIndex Score
15 records- 0198US5712395ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisYISSUM RES DEV CO·Filed 1995·Granted Jan 27, 1998·118 cites·1 claims
- 0297US5763441ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1995·Granted Jun 9, 1998·111 cites·4 claims
- 0395US5792771AQuinazoline compounds and compositions thereof for the treatment of diseaseSUGEN INC·Filed 1995·Granted Aug 11, 1998·155 cites·12 claims
- 0495US5763198AScreening assays for compoundsSUGEN INC·Filed 1994·Granted Jun 9, 1998·155 cites·22 claims
- 0592US6855723B2Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compoundsZENTARIS GMBH·Filed 2002·Granted Feb 15, 2005·53 cites·3 claims
- 0689US6911446B2Methods of modulating serine/threonine protein kinase function with quinazoline-based compoundsSUGEN INC·Filed 2001·Granted Jun 28, 2005·37 cites·17 claims
- 0788US6093728AMethods of modulating serine/threonine protein kinase function with azabenzimidazole-based compoundsASTA MEDICA AG·Filed 1998·Granted Jul 25, 2000·72 cites·11 claims
- 0888US5981569ASubstituted phenylacrylonitrile compounds and compositions thereof for the treatment of diseaseYISSUM RES DEV CO·Filed 1995·Granted Nov 9, 1999·86 cites·16 claims
- 0988US5849742ACompounds for the treament of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1997·Granted Dec 15, 1998·28 cites·14 claims
- 1084US6204267B1Methods of modulating serine/thereonine protein kinase function with quinazoline-based compoundsSUGEN INC·Filed 1998·Granted Mar 20, 2001·61 cites·18 claims
- 1170US6180631B1Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compoundsASTA MEDICA AG·Filed 1998·Granted Jan 30, 2001·25 cites·5 claims
- 1266US6727252B1Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compoundsZENTARIS AG·Filed 2000·Granted Apr 27, 2004·2 cites·6 claims
- 1365US6689560B1Raf protein kinase therapeuticsUS HEALTH·Filed 1994·Granted Feb 10, 2004·20 cites·11 claims
- 1454US2003181413A1Raf protein kinase therapeuticsFiled 2003·Application pending·0 cites
- 1549US5889150AExpression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target protiensUNIV NEW YORK MED CT·Filed 1994·Granted Mar 30, 1999·7 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Harald App files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →